Stock Markets Analysis & Opinion

The global packaging industry has been growing driven by increasing urbanisation, development of retail chains along with the mushrooming healthcare and cosmetics sectors. An increase in living...

We issued an updated research report on Boulder, CO-based Clovis Oncology, Inc. (NASDAQ:CLVS) on Jul 12.Clovis got a huge boost in Dec 2016 when the FDA granted accelerated approval to its PARP...

The U.S. hotel industry started 2017 on a strong note with solid demand supporting modest growth in both occupancy and average daily rate (ADR) in first-quarter 2017. Revenue per available room...

Global data center service provider, Equinix Inc. (NASDAQ:EQIX) , recently announced the eighth phase expansion of its International Business Exchange (IBX) data center in Singapore, named SG2....

Edel AG's (DE:EDLG) interim results show continued progress, particularly at Optimal Media where there was ‘significant’ progress in sales and earnings, buoyed by the continued resurgence...

Vanguard Wellington Investor (VWELX) a Zacks Rank #2 (Buy) seek income and long-term growth of capital without undue risk to capital. The fund's assets are divided between common stocks and bonds,...

MFS Research I (MRFIX) a Zacks Rank #2 (Buy) invests, under normal market conditions, at least 80% of its total assets in common stocks and related securities. The fund focuses on companies that...

Fidelity Select Medical Equipment & Systems (FSMEX) a Zacks Rank #1 (Strong Buy) invests at least 80% of assets in common stocks of companies principally engaged in research, development,...

One of NetScientific’s portfolio companies, PDS Biotechnology (17.4% stake, 14.5% fully diluted), announced on 10 July 2017 that it has entered into a collaboration agreement with Merck...

Barring a few hiccups, the U.S. stock market has displayed a decent run in an economy that witnessed a rise in the benchmark interest rate, recorded sharp rise in U.S. factory activity in June, saw...

Could one of the weakest sectors of the market last quarter turn the page and become one of the strongest this earnings season? A rally on the street today was led by retail of all things. The...

Novartis AG (NYSE:NVS) announced that the FDA Oncologic Drugs Advisory Committee (ODAC) has unanimously (10-0) recommended the approval of immunocellular therapy candidate CTL019...

On Jul 12, Canada‘s central bank hiked its key interest rate for the first time in seven years. The move was widely expected and a reflection of the Bank of Canada’s confidence in the...

This week, Brian Bolan and Terry Ruffolo discuss CSTM and AAOI. Brian is the aggressive growth stock strategist at Zacks and while CSTM doesn’t have the A for growth that he normally likes to...